Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06465888 · ClinicalTrials.gov registry record · NA
Influence of Eggs on Cognitive Performance
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT06465888: Completed NA study, sponsored by Texas A&M University.
NCT06465888 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06465888, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
This clinical trial aims to evaluate the nutrients in eggs in healthy adult's cognitive performance. The main questions it aims to answer are: * How do the nutrients in eggs impact visual cognitive performance (VCP) in generally healthy older individuals? * Will omega-3 fatty acids in eggs improve VCP in generally healthy older individuals? Participants will be randomly placed in one of five dietary treatment groups, including four egg whites, two whole regular eggs, two whole omega-3 fortified eggs, four egg yolks, and a no-egg control. Blood will be drawn at baseline. During the first two weeks, participants will eat assigned eggs, consume their usual diet other than the eggs, and keep five food logs. Cognitive performance testing will start on day 15 and be measured over a 10-day period using the Neurotracker (NT) 3-D program. Data on ancillary factors influencing outcomes will be collected, and food will be logged on each NT training day. Blood will be drawn at the end of the study and compared with baseline levels.
Primary Outcome
Neurotracker 3-Dimensional software used to measure cognitive performance. Subjects performed 20 trials within a single training session obtaining a "speed threshold," (ST) the level at which the participant correctly tracked and selected the correct objects 50% of the time. The final ST for each training session and the progression over 15 sessions were the primary determinants of cognitive performance.
Interventions
- OTHER egg whites
- OTHER whole eggs
- OTHER Omega-3 eggs
- OTHER egg yolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2017-08-22 |
| Est. Completion | 2020-03-19 |
| Phase | NA |
What the finished NCT06465888 record still lists
NCT06465888 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 4 interventions - of which egg whites is the first listed.
NCT06465888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06465888 about?
NCT06465888 is a clinical study titled "Influence of Eggs on Cognitive Performance". This clinical trial aims to evaluate the nutrients in eggs in healthy adult's cognitive performance. The main questions it aims to answer are: * How do the nutrients in eggs impact visual cognitive performance (VCP) in generally healthy older individuals? * Will omega-3 fatty acids in eggs improve ...
What is the current status of trial NCT06465888?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2017-08-22. Estimated completion is 2020-03-19.
What interventions are being tested in trial NCT06465888?
The interventions under investigation include: egg whites (OTHER), whole eggs (OTHER), Omega-3 eggs (OTHER), egg yolk (OTHER).
Who is sponsoring clinical trial NCT06465888?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06465888's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI